[go: up one dir, main page]

WO2018013493A1 - Dispositif d'administration alimenté - Google Patents

Dispositif d'administration alimenté Download PDF

Info

Publication number
WO2018013493A1
WO2018013493A1 PCT/US2017/041406 US2017041406W WO2018013493A1 WO 2018013493 A1 WO2018013493 A1 WO 2018013493A1 US 2017041406 W US2017041406 W US 2017041406W WO 2018013493 A1 WO2018013493 A1 WO 2018013493A1
Authority
WO
WIPO (PCT)
Prior art keywords
housing
delivery
delivery module
energy source
stored energy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2017/041406
Other languages
English (en)
Inventor
Siddharth Desai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Heron Therapeutics LLC
Original Assignee
Heron Therapeutics LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Heron Therapeutics LLC filed Critical Heron Therapeutics LLC
Publication of WO2018013493A1 publication Critical patent/WO2018013493A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/20—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
    • A61M5/2053—Media being expelled from injector by pressurised fluid or vacuum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/20—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
    • A61M5/2046—Media being expelled from injector by gas generation, e.g. explosive charge
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/24—Ampoule syringes, i.e. syringes with needle for use in combination with replaceable ampoules or carpules, e.g. automatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/44—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests having means for cooling or heating the devices or media
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/48—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests having means for varying, regulating, indicating or limiting injection pressure
    • A61M5/484—Regulating injection pressure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/002—Packages specially adapted therefor, e.g. for syringes or needles, kits for diabetics
    • A61M2005/005—Magazines with multiple ampoules directly inserted into an injection or infusion device, e.g. revolver-like magazines containing ampoules with or without needles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/24—Ampoule syringes, i.e. syringes with needle for use in combination with replaceable ampoules or carpules, e.g. automatic
    • A61M2005/2403—Ampoule inserted into the ampoule holder
    • A61M2005/2411—Ampoule inserted into the ampoule holder from the front

Definitions

  • the subject matter described herein relates to a device for powered delivery of an agent.
  • typical syringe systems require the user to exert significant force on the enlarged proximal end of the plunger rod being depressed causing a reduction in control of the injection and prolonging the delivery, and potentially leading to failure of the plunger rod because of the high point load on the rod end.
  • a delivery device that includes an internal power source that provides enhanced control and ease of use when dispensing highly viscous materials. It would be a further advantage to provide a delivery device that allows the injection of high viscosity substances with only one hand. It would be a further advantage to provide delivery device which may be used with pre-filled syringe products. It would be yet a further advantage to provide a delivery device which may be used to deliver multiple doses of highly viscous materials.
  • a device for delivery of a viscous or highly viscous material comprises (a) a housing having a proximal end and a distal end; (b) a power mechanism comprising a stored energy source being positioned within the housing; (c) a pressure regulator positioned within the housing proximal to the power mechanism; (d) a delivery module operatively coupled to the housing distal to the pressure regulator, and (e) an activation mechanism for operating the power mechanism such that the stored energy source acts on the plunger to deliver the viscous material through the needle.
  • the delivery module comprises (i) an elongated chamber for holding the material and comprising an opening at a proximal end; (ii) a plunger positioned within the delivery module; and (iii) a needle operatively coupled to the opening.
  • the stored energy source is a spring. In other embodiments, the stored energy source is a pneumatic cartridge. In embodiments, the pneumatic cartridge comprises at least one compressed gas or liquid. In embodiments, the stored energy source provides a force of about 50-200 Newtons. In embodiments, the power mechanism provides delivery of the material at a rate of about 0.05-0.1 mL/second.
  • the housing further comprises a connection mechanism for coupling the delivery module to the housing.
  • the connection mechanism is a releasable mechanism.
  • the delivery module is at least partially positioned within the housing.
  • the device further includes a heating mechanism positioned at least partially within or contacting the housing.
  • the device further comprises a holder coupled to the housing and configured to hold two or more delivery modules, wherein the holder comprises a rotating or sliding mechanism for sequentially moving each of the two or more delivery modules into alignment with the housing.
  • the viscous or highly viscous material is a pharmaceutical composition comprising at least one active agent and a pharmaceutically acceptable vehicle.
  • the vehicle comprises at least one polymer.
  • at least one of the at least one polymer is a polyorthoester.
  • the polyorthoester is represented by the structure shown as Formula III,
  • A is R 1 or R 3 , R* is C1 -4 alkyl,
  • n ranges from 5 to 1000
  • p and q are integers that vary from between about 1 to 20 and the average number of p or the average of the sum of p and q is between 1 and 7;
  • R 3 and R 6 are each independently:
  • x is an integer of 0-10;
  • R 5 is H or methyl
  • the fraction of A units that are of formula R 1 is between 0 and 25 mole percent.
  • the composition further comprises one or more aprotic solvents selected from at least one of dimethyl sulfoxide, dimethyl acetamide, N-methyl pyrrolidone.
  • a method of delivering a viscous or highly viscous material comprises operatively connecting a delivery module containing the material to a proximal end of a delivery device housing, the delivery module comprising an opening and a plunger; and activating a power mechanism comprising a stored energy source within the delivery device to thereby move the plunger within the delivery module to deliver the material through the delivery module opening.
  • the material has a viscosity of at least about 500 centipoise.
  • the power module is activated by a trigger mechanism.
  • the trigger mechanism controls the release of energy from the stored energy source.
  • the delivery module is at least partially inserted into a proximal end of the housing.
  • the delivery device comprises one or more compartments comprising the material.
  • the material is delivered from the delivery module opening at a rate of between about 0.05-0.1 mL/second.
  • the fluid is delivered from the delivery module at a continuous rate.
  • the stored energy source provides force of at least about 50-200 Newtons on the plunger.
  • the method includes heating the material before, during and/or after delivering the material.
  • the viscous or highly viscous material is a pharmaceutical composition comprising at least one active agent and a pharmaceutically acceptable vehicle.
  • the vehicle comprises at least one polymer.
  • at least one of the at least one polymer is a polyorthoester.
  • the polyorthoester is represented by the structure shown as Formula III,
  • A is R 1 or R 3 ,
  • R* is C1 -4 alkyl
  • n ranges from 5 to 1000
  • p and q are integers that vary from between about 1 to 20 and the average number of p or the average of the sum of p and q is between 1 and 7;
  • R 3 and R 6 are each independently:
  • x is an integer of 0-10;
  • R 5 is H or methyl
  • the fraction of A units that are of formula te R 1 is between 0 and 25 mole percent.
  • the composition further comprises one or more aprotic solvents selected from at least one of dimethyl sulfoxide, dimethyl acetamide, N-methyl pyrrolidone.
  • FIG. 1 is an illustration of a delivery device in one embodiment.
  • FIG. 2 is an illustration of a delivery device in one embodiment.
  • FIGS. 3A-3C are illustrations of modules of the delivery device in some embodiments.
  • FIGS. 4A-4B are illustrations of embodiments of housing configurations in some embodiments.
  • FIG. 5 is an illustration of a delivery device in one embodiment.
  • a device for delivering a therapeutic agent such as a viscous or highly viscous material is best understood by reference to Figs. 1 -5.
  • the device is described and exemplified with regard to delivery of a viscous or highly viscous material. It will be understood, of course, that the same disclosure and principles apply to the delivery of various other substances, material, fluids and the like. Reference to the material hereafter is made to a viscous material; however, it will be understood that the disclosure hereafter applies to a highly viscous material.
  • the device is useful for to improve delivery of viscous and/or highly viscous materials, substances or fluids by powered means.
  • the device includes a power mechanism that makes it easily possible to apply a much higher pressure to the viscous material.
  • the device dispenses the viscous material with increased control of the dispensing process including the delivery rate and amount of material that may be delivered.
  • a powered delivery device 10 comprises a housing 12, one or more power mechanisms 14, and one or more delivery modules 16.
  • the delivery module is operatively coupled to the housing using any suitable means as known in the art.
  • the housing distal end includes a connector that is threaded to match a connector on the delivery module.
  • the delivery module may be inserted at least partially into the housing to form a tight seal with a portion of the housing such that the housing holds the delivery module.
  • the housing includes a quick connect/disconnect connector 30 as known in the art.
  • the quick connect/disconnect connector is a screw type connector where the connector includes a collar that is rotated to tighten against the housing in order to narrow the opening or tighten against the delivery module. In this embodiment, the collar may be rotated the opposite direction to loosen and allow the delivery module to be disconnected from the housing.
  • the delivery module 16 includes an elongate chamber 70 for holding the viscous material.
  • the elongate chamber includes an open distal end 72 and an opening 24 at the distal end.
  • the delivery module is preloaded with the viscous material.
  • the elongate chamber may be of any suitable size for holding the desired amount of viscous material and/or for connecting to the housing.
  • the elongate chamber may be formed of any suitable material, including but not limited to, plastics, glass, ceramics, and polymers including polycarbonate.
  • the chamber is formed of a shatter-proof material.
  • the elongate chamber is formed of a transparent, semi-transparent material to allow a user to visually inspect the viscous material and/or operation of the device.
  • the chamber includes graduations or markings to indicate the volume of material in the chamber and/or volume of material dispensed.
  • the elongate chamber may be any suitable size (width and/or length) to hold the desired volume of a material to be dispensed.
  • the elongate chamber is sized to contain at least about 0.5-10 ml_ of a material to be delivered.
  • the chamber is sized to contain at least about 1 -10 ml_, 1 -5 ml_ or 1 -3 ml_.
  • the elongate chamber contains or is configured to contain a pharmaceutical composition.
  • the composition is a viscous liquid with a viscosity, e.g., from about 10 to about 250,000 centipoise (cp). In some embodiments, the composition is a viscous liquid with a viscosity from about 10 cp to about 100,000 cp.
  • the composition is a viscous liquid with a viscosity from about 10-500 cp, about 10-3000 cp, about 10-5000 cp, about 10-12,000, about 10-24,000 cp, about 10-80,000 cp, about 10-130,000, about 3000-5000 cp, about 3000-12,000, about 3000-24,000 cp, about 3000-80,000 cp, about 3000-130,000, about 5000-12,000, about 5000-24,000 cp, about 5000-80,000 cp, about 5000-130,000, about 12,000-24,000 cp, about 12,000-80,000 cp, about 12,000-130,000, about 24,000-80,000 cp, about 24,000-130,000, or about 80,000-130,000 cp.
  • the viscous liquid has a viscosity of at least about or from about 10 cp, about 500 cp, about 3000 cp, about 5000 cp, about 12,000 cp, about 24,000 cp, about 80,000 cp, or about 130,000 cp.
  • the composition is comprised of an active agent and a vehicle.
  • the composition has a viscosity of at least about 500 cp.
  • the viscosity is measured at 37 °C or 25 °C. In some embodiments, the viscosity is measured using a cone and plate viscometer.
  • the chamber is prefilled with the composition.
  • Any active agent can be used in order to treat any disease or condition.
  • the active agent is an anti-emetic such as a 5-HT3 receptor antagonist including but not limited to ondansetron, palonosetron, tropisetron, lehsetron, alosetron, granisetron, dolasetron, bernesetron, ramosetron, azasetron, itasetron, zacopride, cilansetron or pharmaceutically acceptable salts thereof.
  • the active agent is granisetron and the disease or condition is chemotherapy induced nausea and vomiting (e.g., acute or delayed onset). Additional active agents include, but are not limited to local anesthetic pain management medication such as a ropivacaine, bupivacaine, lidocaine and levobuipvacaine.
  • the vehicle can be any suitable polymer that can be utilized to deliver an active agent by either immediate or controlled release.
  • a controlled release composition of the present invention can deliver an active agent e.g., from about 1 to about 7 days.
  • the vehicle is a polymer such as a polyorthoester. Some exemplary polyorthoesters are described in U.S. Publication No. 2014-0275145, the disclosure of which is incorporated by reference herein.
  • the vehicle is a polymer such as a polyorthoester.
  • the composition comprises (i) a polyorthoester represented by the structure shown as Formula III,
  • A is R 1 or R 3 ,
  • R* is C1 -4 alkyl
  • n ranges from 5 to 1000
  • p and q are integers that vary from between about 1 to 20 and the average number of p or the average of the sum of p and q is between 1 and 7;
  • R 3 and R 6 are each independently:
  • the fraction of A units that are of formula te R 1 is between 0 and 25 mole percent
  • a solvent consisting essentially of one or more aprotic solvents, wherein at least one of the one or more aprotic solvents is an aprotic solvent such as dimethyl sulfoxide, dimethyl acetamide, N-methyl pyrrolidone, and combinations thereof in which the polyorthoester is miscible to form a liquid single phase; and
  • a local anesthetic selected from the group consisting of bupivacaine, levobupivacaine, dibucaine, mepivacaine, procaine, lidocaine, tetracaine, and ropivacaine, and their pharmaceutically acceptable salts, dispersed or solubilized in the single phase.
  • the anesthetic is released from the composition over a period of between approximately 1 day and approximately 8 weeks when measured by an in vitro dissolution test at 37 °C in phosphate buffered saline.
  • A is R 1 in 0 to
  • the polyorthoester has a molecular weight between about 1 ,000 and 10,000 Daltons.
  • the polyorthoester includes one or more subunits selected from
  • x is an integer from 1 -4
  • the total amount of p is an integer from 1 -20, and
  • s is an integer from 1 -4.
  • the composition comprises one or more aprotic solvents present in an amount between 10-60 percent by weight of the composition.
  • the active agent such as a local anesthetic, is present in the composition in an amount between 2 and 5 percent by weight of the delivery system.
  • the rate of solvent release from the system correlates with the rate of release of the active agent.
  • the delivery module 16 includes a plunger assembly 18 at least partly positioned within the elongate chamber 70.
  • the plunger assembly is slidably positioned within the chamber for sliding movement along at least a portion of the chamber.
  • the plunger assembly is positioned within the chamber between the composition at the proximal end and a power mechanism. As will be described further below, when the power mechanism is activated, a stored energy source acts on the plunger to move the plunger within the chamber toward the chamber proximal end thereby pushing the composition out of the chamber for delivery.
  • the plunger assembly 18 includes a head 48 and a distal push section 52 connected by a shaft 50.
  • the head comprises a top side 74 and a bottom side 76.
  • the plunger shaft 50 extends from the bottom side of the plunger head between the plunger head and the distal push section 52.
  • the top side of the plunger head may have any shape as suitable for pushing the composition through the chamber. In some embodiments, the top side of the plunger head has a flat or convex shape.
  • the plunger head has a width or diameter such that the plunger head makes a liquid and/or airtight seal with the inner wall of the elongate chamber in order to push the composition through the chamber.
  • the head, shaft and/ or distal push section may be formed as a single piece and/or as separate pieces.
  • the plunger may be formed of any suitable material.
  • at least a portion of the plunger is formed of a plastic, glass, ceramic, metal, silicon, rubber, or composites thereof.
  • at least a portion of the plunger is formed of a thermoplastic material.
  • at least a portion of the plunger is formed of a polydimethyl thermoset material.
  • An optional needle assembly 22 is attached to the distal end of the delivery module, in some embodiments.
  • the needle can be any gauge but preferably has a gauge of between about 31 gauge to about 12 gauge. In some embodiments, the needle has a gauge of between about 23 to 18 gauge or about 26 to 18 gauge. In some embodiments, the needle has a length of about 1 -4 inches in length. In some embodiments, the needle acts as a damper by way of the needle's exit size. It will be appreciated that the opening in the chamber may also act as a damper. In some embodiments, the device includes a damper mechanism as known in the art in or around the delivery module or within the housing.
  • a power mechanism 14 is positioned at least partially within the housing.
  • the power mechanism comprises one or more stored energy sources that act on the plunger distal push section 52.
  • the power mechanism and one or more stored energy sources must provide sufficient force on the plunger to dispense the viscous material.
  • the power mechanism and one or more stored energy sources provide a force of about 50-200 Newtons.
  • the power mechanism and one or more stored energy sources provide a flow rate of the viscous material of about 10-15 mL/second.
  • the power mechanism and one or more stored energy sources provide sufficient force to delivery about 3 ml_ of the viscous material in about 35-40 seconds.
  • the power mechanism produces pressure of less than about 40 psi. Excessive pressure during delivery can cause backpressure and/or damage.
  • the stored energy source is activated by an activation mechanism 26 such as a trigger or lever coupled to the housing and the stored energy source.
  • the trigger or lever may be an on/off type switch or a trigger/lever that provides differential force from the power mechanism.
  • the activation mechanism provides continuous delivery of the viscous material when activated (e.g. pressed).
  • the activation mechanism may activate the energy source to provide continuous delivery of the material or a fixed bolus volume of the material.
  • the device includes a flow indicator 64 to indicate flow of the viscous material from the device.
  • the device includes one or more flow sensors as known in the art.
  • the device includes at least two pressure sensors to measure pressure within the device at two or more separated positions. The pressure differential between the measurements is used to determine the flow, which is shown by the flow indicator.
  • the housing preferably has a shape allowing the device to fit comfortably in one hand.
  • the housing has an ergonomic shape.
  • Figs. 4A-4B show two exemplary configurations for the housing.
  • Fig. 4A illustrates a pen style configuration.
  • the proximal end of the housing 12 is an elongate cylinder 60. This embodiment may be held in one hand similar to holding a pen with one finger able to operate the activation mechanism.
  • the embodiment of Fig. 4B includes an ergonomic grip 62 at the distal end of the housing.
  • the housing includes a hand or finger rest 58 to facilitate comfort and/or ability to use the device with one hand.
  • the housing proximal end includes an opening that may be used to insert the power mechanism. The opening may sealed or plugged during delivery of the viscous material.
  • the stored energy source is a pneumatic energy source.
  • the stored energy source is a compressed gas or liquid module or cartridge. Any suitable compressed gas or liquid may be used.
  • the gas is an inert gas.
  • the gas is selected from carbon dioxide, nitrogen, air or other compressible gases.
  • stored energy source comprises a liquid form of nitrogen, carbon dioxide or a liquid form of other known compressible gases.
  • the pneumatic energy source may be replaced within the housing so that at least a portion of the device is reusable.
  • the pneumatic energy source may be useful for delivery of a viscous material from one or more delivery modules.
  • the device includes a valve such as a poppet valve connected to the pneumatic energy source and the activation mechanism to stop flow of the gas/liquid from the energy source when the activation mechanism is no longer activated (e.g. pressed).
  • the device includes an indicator to show when the energy source is empty or needs replacement.
  • the device includes a safety mechanism whereby the pneumatic/liquid energy source will only release gas/liquid when the device is integrated as a unit.
  • the stored energy source is a spring 34.
  • the spring is a compression spring.
  • the spring is retained in the housing in a compressed or restrained position until use. Activation of the activation mechanism at least partially releases the spring to travel to an extended position where the spring acts on the plunger to deliver the composition.
  • the activation mechanism releases the spring from a restrained position to a partial or fully elongate position.
  • the activation mechanism provides incremental release of the spring by adjusting the compression of the spring.
  • the device includes one or more restraining members that hold the spring in a constrained position until activated.
  • the restraining members are a safety feature to prevent premature expansion of the spring that can be negated or removed prior to delivery of the viscous material.
  • the force applied by a spring is determined at least in part by the length of the spring, material used, wire diameter, and pitch of the spring.
  • the spring may be configured to provide the desired force according to methods known in the art.
  • the spring energy source may be reset by compressing the spring after release.
  • the spring energy source may be useful for delivery of a viscous material from one or more delivery modules.
  • the power mechanism is modular and may be replaced within the housing. In this manner, at least a portion of the device is reusable.
  • a spring energy source may be selected based on the viscosity of the material and/or the volume of material to be delivered. In this manner, a spring providing greater force may be selected and included in the housing for delivery of larger volumes and/or more viscous materials.
  • the spring may be formed of any suitable material including, but not limited to, a metal and a polymer/copolymer. In one embodiment, the spring is formed of a stainless steel, e.g. 304 ss.
  • the device includes a pressure regulator.
  • the pressure regulator may regulate release of the gas/liquid for pneumatically powered devices or moderate compression of a spring. By regulating operation of the stored energy source, the pressure regulator regulates pressure applied to the plunger.
  • the housing may be formed of any suitable material as known in the art that provides the required rigidity to hold the power mechanism and/or the delivery module. It will be appreciated that the housing may be formed of one or more materials. In some non- limiting embodiments, the housing is at least partially formed of a plastic, one or more polymers or copolymers, a ceramic, silicon, and a metal. In some embodiments the polymer is selected from polycarbonate (including reinforced polycarbonate) and Acrylonitrile Butadiene Styrene (ABS).
  • ABS Acrylonitrile Butadiene Styrene
  • the device includes a heater for raising the temperature of the viscous material. Heating the material can reduce the force required to deliver the material from the device. When the material is heated, the viscosity of the material is reduced and the overall force required to move the material through the device and delivery it is reduced. The force required to delivery the material is based on the Hagen Poisuelle equation:
  • the force required to delivery the material is directly proportional to the viscosity of the material. Therefore, reducing the viscosity of the material by heating reduces the force necessary for delivery from the device.
  • the device is configured to hold two or more delivery modules where the device is configured to alternatively dispense material from one or more of the deliver modules.
  • the device may include a holder 66 for fixedly holding two or more delivery modules.
  • the holder is coupled to the housing.
  • the holder aligns one of the delivery modules with the distal end of the housing to allow the power mechanism positioned within the housing to act on the plunger in the delivery module as described above.
  • the next delivery module 68 is moved into position for delivery.
  • the holder is a rotating holder and each module is rotated into position for delivery of the viscous material.
  • the holder includes a sliding mechanism and each delivery module is slid into delivery position.
  • a device for delivery of a viscous or highly viscous material comprising:
  • a power mechanism comprising a stored energy source being positioned within the housing;
  • a delivery module operatively coupled to the housing distal to the pressure regulator comprising:
  • the housing further comprising a connection mechanism for coupling the delivery module to the housing.
  • connection mechanism is a releasable mechanism.
  • the device of the combined or separate embodiments 1 -8 the delivery module being at least partially positioned within the housing. 10. The device of the combined or separate embodiments 1 -9, further comprising a heating mechanism positioned within the housing.
  • the device of the combined or separate embodiments 1 -10 further comprising a holder coupled to the housing and configured to hold two or more delivery modules,
  • the holder comprises a rotating or sliding mechanism for sequentially moving each of the two or more delivery modules into alignment with the housing.
  • the viscous or highly viscous material is a pharmaceutical composition comprising at least one active agent and a pharmaceutically acceptable vehicle.
  • A is R 1 or R 3 ,
  • R* is C1 -4 alkyl
  • n ranges from 5 to 1000
  • p and q are integers that vary from between about 1 to 20 and the average number of p or the average of the sum of p and q is between 1 and 7;
  • R 3 and R 6 are each independently:
  • x is an integer of 0-10;
  • R 5 is H or methyl
  • the fraction of A units that are of formula R 1 is between 0 and 25 mole percent. 16.
  • the composition further comprises one or more aprotic solvents selected from at least one of dimethyl sulfoxide, dimethyl acetamide, N-methyl pyrrolidone.
  • a method of delivering a viscous or highly viscous material comprising:
  • a delivery module containing the material operatively connecting a delivery module containing the material to a proximal end of a delivery device housing, the delivery module comprising an opening and a plunger;
  • a power mechanism comprising a stored energy source within the delivery device to thereby move the plunger within the delivery module to deliver the material through the delivery module opening.
  • A is R 1 or R 3 ,
  • R* is C1 -4 alkyl
  • n ranges from 5 to 1000
  • p and q are integers that vary from between about 1 to 20 and the average number of p or the average of the sum of p and q is between 1 and 7;
  • R 3 and R 6 are each independently:
  • x is an integer of 0-10;
  • R 5 is H or methyl
  • the fraction of A units that are of formula R 1 is between 0 and 25 mole percent.
  • composition further comprises one or more aprotic solvents selected from at least one of dimethyl sulfoxide, dimethyl acetamide, N-methyl pyrrolidone.

Landscapes

  • Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

L'invention concerne un dispositif (10) servant à administrer un matériau visqueux ou hautement visqueux, ainsi que des utilisations associées. Le dispositif (10) selon l'invention comprend un logement (12), un mécanisme d'alimentation (14) et un module d'administration (16). Le mécanisme d'alimentation (14) sert à administrer le matériau à partir du module d'administrtaion (16).
PCT/US2017/041406 2016-07-11 2017-07-10 Dispositif d'administration alimenté Ceased WO2018013493A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662360875P 2016-07-11 2016-07-11
US62/360,875 2016-07-11

Publications (1)

Publication Number Publication Date
WO2018013493A1 true WO2018013493A1 (fr) 2018-01-18

Family

ID=59383642

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2017/041406 Ceased WO2018013493A1 (fr) 2016-07-11 2017-07-10 Dispositif d'administration alimenté

Country Status (1)

Country Link
WO (1) WO2018013493A1 (fr)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020012341A1 (fr) * 2018-07-12 2020-01-16 Alcon Inc. Procédés et systèmes pour distribuer un matériau au niveau d'une partie du corps
US10869966B2 (en) 2015-02-20 2020-12-22 Regeneron Pharmaceuticals, Inc. Syringe systems, piston seal systems, stopper systems, and methods of use and assembly
CN112401989A (zh) * 2020-11-09 2021-02-26 峡江县飞福科技有限公司 一种可调式肿瘤治疗介入装置及使用方法
CN115624374A (zh) * 2022-10-28 2023-01-20 中国人民解放军总医院第三医学中心 一种带有神经阻滞穿刺针的麻醉机器人
US12226614B2 (en) 2020-12-31 2025-02-18 Regeneron Pharmaceuticals, Inc. Auto-injector and related methods of use

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998017332A2 (fr) * 1996-10-25 1998-04-30 D'antonio Consultants International, Inc. Dispositif d'administration hypodermique de fluide
EP2066276A2 (fr) * 2006-10-16 2009-06-10 Alcon Research, Ltd. Dispositif d'injection ophtalmique jetable
US20130317478A1 (en) * 2012-05-24 2013-11-28 Ataviz LLC Viscous fluid injector
US20140275145A1 (en) 2013-03-15 2014-09-18 Heron Therapeutics, Inc. Compositions of a polyorthoester and an aprotic solvent
US20140323517A1 (en) * 2013-04-30 2014-10-30 Heron Therapeutics, Inc. Compositions and methods for injection of a biodegradable polymer-based delivery system
US8932268B1 (en) * 2013-09-23 2015-01-13 Edward D. Struzinski Medication cartridge injection assembly
DE202015006842U1 (de) * 2015-09-30 2016-01-15 Haselmeier Ag Injektionsgerät

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998017332A2 (fr) * 1996-10-25 1998-04-30 D'antonio Consultants International, Inc. Dispositif d'administration hypodermique de fluide
EP2066276A2 (fr) * 2006-10-16 2009-06-10 Alcon Research, Ltd. Dispositif d'injection ophtalmique jetable
US20130317478A1 (en) * 2012-05-24 2013-11-28 Ataviz LLC Viscous fluid injector
US20140275145A1 (en) 2013-03-15 2014-09-18 Heron Therapeutics, Inc. Compositions of a polyorthoester and an aprotic solvent
US20140323517A1 (en) * 2013-04-30 2014-10-30 Heron Therapeutics, Inc. Compositions and methods for injection of a biodegradable polymer-based delivery system
US8932268B1 (en) * 2013-09-23 2015-01-13 Edward D. Struzinski Medication cartridge injection assembly
DE202015006842U1 (de) * 2015-09-30 2016-01-15 Haselmeier Ag Injektionsgerät

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10869966B2 (en) 2015-02-20 2020-12-22 Regeneron Pharmaceuticals, Inc. Syringe systems, piston seal systems, stopper systems, and methods of use and assembly
WO2020012341A1 (fr) * 2018-07-12 2020-01-16 Alcon Inc. Procédés et systèmes pour distribuer un matériau au niveau d'une partie du corps
US11801343B2 (en) 2018-07-12 2023-10-31 Alcon Inc. Methods and systems for delivering material to a body part
CN112401989A (zh) * 2020-11-09 2021-02-26 峡江县飞福科技有限公司 一种可调式肿瘤治疗介入装置及使用方法
US12226614B2 (en) 2020-12-31 2025-02-18 Regeneron Pharmaceuticals, Inc. Auto-injector and related methods of use
CN115624374A (zh) * 2022-10-28 2023-01-20 中国人民解放军总医院第三医学中心 一种带有神经阻滞穿刺针的麻醉机器人

Similar Documents

Publication Publication Date Title
WO2018013493A1 (fr) Dispositif d'administration alimenté
US7959612B2 (en) Dual syringe injector system
KR101386532B1 (ko) 무바늘 주사기를 위한 충전 기구
US10420888B2 (en) Double-chamber mixing syringe and method of use
TWI224517B (en) Pneumatic powered autoinjector
US11883588B2 (en) Method of operating a nasal drug delivery device
US9987163B2 (en) Device for dispensing intraocular substances
EP2432528B1 (fr) Système d'administration de stéroïde
JPH11514255A (ja) 複数投与注射器ドライバー
US20050192530A1 (en) Method and apparatus for needle-less injection with a degassed fluid
WO2009044401A2 (fr) Pompe à médicament externe
JP2013540488A (ja) 無針注射器および注射性能を最適化する同注射器の設計パラメータ
EP1257307A2 (fr) Entraineur de seringue multi-dose
JP5978267B2 (ja) 高圧の注射のための開閉バルブの薬物送達システム
US20250009972A1 (en) Systems, devices, and methods for fluidic throttle control of the delivery of therapies in needle-based delivery systems
JP2016536052A (ja) ロックアウトを有する患者自己管理式の薬剤の大量ボーラス投与装置
JP2015520625A (ja) 薬物送達カプセルのためのピストン施栓
AU2024203640A1 (en) Syringe Infusion Devices And Systems For Delivery Of Active Agents
US20160331899A1 (en) Syringe actuator system for delivering toxic medical compositions
NZ589368A (en) A syringe cartridge applicator with a syringe cap removal mechanism that operates on advance of a syringe

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 17742602

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 17742602

Country of ref document: EP

Kind code of ref document: A1